On Tuesday, surgeons at a Rome hospital performed a lobectomy on Pope Leo XIV, removing the lower lobe of his right lung after scans detected a small growth subsequently confirmed as lung cancer. The procedure — video-assisted keyhole surgery, the current standard of care — is the most common surgical treatment for early-stage non-small cell lung cancer. For many patients, it is the only treatment they will ever need. The lungs have five lobes: three on the right, two on the left. Removing an entire lobe rather than excising just the tumour gives surgeons a clean margin and the best chance of capturing every cancer cell. People live full, active lives on four lobes. Surgeons also extracted nearby lymph nodes for examination — the critical variable the Vatican has not yet disclosed. If those nodes are clear, surgery alone is often curative. The speed of diagnosis is notable but not mysterious. The Vatican confirmed the cancer during the operation itself, likely via frozen section analysis — a technique where tissue is rapidly frozen, sliced, and examined under a microscope while the patient remains on the table. This gives pathologists an answer in minutes and helps surgeons calibrate how much tissue to remove. A fuller pathology report follows in the days ahead. The pope's cancer is adenocarcinoma, the most common subtype of non-small cell lung cancer, which accounts for roughly 85% of all lung cancers. Adenocarcinoma typically grows in the outer parts of the lung and is the most common form in people who have never smoked. Many such tumours are found incidentally on scans done for unrelated reasons — as appears to have happened here. The immediate recovery trajectory is standard: a chest drain to let air and fluid escape, mobilisation the next day to prevent clots and infection, and an expected hospital stay of about a week. The keyhole approach means less pain, smaller incisions, and faster recovery compared to the open thoracotomy that was once standard. The real decision point comes with the final pathology report. Adenocarcinomas are now routinely tested for specific genetic mutations that targeted drugs can address. Depending on the tumour's molecular profile and lymph node status, Pope Leo could be offered immunotherapy, chemotherapy, or targeted therapy to reduce recurrence risk — or he could need nothing further at all. As for travel, most patients are advised to wait two to three weeks before flying after a lobectomy. That leaves a narrow but realistic window for the pope's planned overseas trip in November, provided healing proceeds normally. The next 7-14 days — waiting for the full pathology and lymph node results — are where the medical story actually lives.
